AIC
AUPH icon

AWM Investment Company’s Aurinia Pharmaceuticals AUPH Stock Holding History

AWM Investment Company’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-73,500
Closed -$806K – 114
2023
Q1 		$806K Buy
+73,500
New +$648K 0.11% 95
2018
Q1 		– Sell
-354,520
Closed -$1.61M – 93
2017
Q4 		$1.61M Buy
354,520
+2,020
+0.6% +$11.2K 0.31% 71
2017
Q3 		$2.21M Hold
352,500
– – 0.39% 60
2017
Q2 		$2.16M Buy
352,500
+52,500
+18% +$354K 0.38% 61
2017
Q1 		$2.2M Buy
+300,000
New +$1.39M 0.41% 62

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AWM Investment Company's AUPH Position: Q2 2023 in Review

AWM Investment Company sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2023, closing a stake of 73,500 shares — an estimated $806K sold.

AWM Investment Company first reported a position in AUPH in Q1 2017 and held it in 5 quarters. The position peaked at $2.21M in Q3 2017. 200 funds tracked by Wall St. Rank hold AUPH as of Q2 2023.

  • AWM Investment Company reported no remaining Aurinia Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • AWM Investment Company sold 73,500 Aurinia Pharmaceuticals shares in Q2 2023, an estimated $806K.
  • AWM Investment Company first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 5 quarters.
  • AWM Investment Company's Aurinia Pharmaceuticals position peaked at $2.21M in Q3 2017.
  • 200 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2023.

Based on AWM Investment Company's 13F filing for Q2 2023, filed 11 Aug 2023.